Extra Time on Brazilian College Level Exam for Students With and Without ADHD

October 3, 2023 updated by: Hospital de Clinicas de Porto Alegre

Extended Time on Exams as an Accommodation at First Level of Higher Education: A Randomized Controlled Study

Standardized tests such as the Scholastic Aptitude Test (SAT) and the brazilian National High School Exam (ENEM) give more time for students with Attention Deficit and Hyperactivity Disorders (ADHD) to complete the exam. The goal of this study is to find out if giving students with ADHD more time on tests actually helps them. Additionally, the research aims to find out if more time helps students without ADHD too or not, or even if it only helps students with certain traits.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Initially, the participants of this study will fill out forms and questionnaires online. Then, they will go through a psychiatric evaluation, where they will talk to a psychiatrist, and neuropsychological testing, where they will do some mental activities. Later on, they will do a mock test of the ENEM, with and without extra time.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Brazil
    • Rio Grande Do Sul
      • Porto Alegre, Rio Grande Do Sul, Brazil, 90035903
        • Recruiting
        • Hospital de Clinicas de Porto Alegre
        • Contact:
          • Luis Augusto Paim Rohde, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Brazilian citizen;
  • Planing to participate in college-entry standardized tests (ENEM, Vestibulares);

Exclusion Criteria:

  • Medical condition and/or disability that may hinder the neuropsychological testing;
  • Intelligence Quotient (IQ) lower than 80;
  • Psychotic disorders, bipolar disorders, current moderate or severe depressive episode, suicide risk, autism spectrum disorders, learning disabilities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Standard time
40 minutes provided to complete the exam.
Behavioral: Exam
Academic exam based on the Brazilian National High School Exam (ENEM).
Other Names:
  • ENEM
  • Brazilian National High School Exam
Experimental: 25% extra time
50 minutes provided to complete the exam.
Behavioral: Exam
Academic exam based on the Brazilian National High School Exam (ENEM).
Other Names:
  • ENEM
  • Brazilian National High School Exam
Experimental: 50% extra time
60 minutes provided to complete the exam.
Behavioral: Exam
Academic exam based on the Brazilian National High School Exam (ENEM).
Other Names:
  • ENEM
  • Brazilian National High School Exam

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Test performance
Time Frame: During Intervention
Proportion of correct answers weighted by item difficulty, according to the standard scoring of this exam.
During Intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time spent
Time Frame: During Intervention
Time spent doing the exam.
During Intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospital de Clinicas de Porto Alegre

Investigators

  • Principal Investigator: Luis Augusto Paim Rohde, PhD, Hospital de Clinicas de Porto Alegre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2023

Primary Completion (Estimated)

January 1, 2024

Study Completion (Estimated)

March 1, 2024

Study Registration Dates

First Submitted

September 18, 2023

First Submitted That Met QC Criteria

September 29, 2023

First Posted (Actual)

October 2, 2023

Study Record Updates

Last Update Posted (Actual)

October 5, 2023

Last Update Submitted That Met QC Criteria

October 3, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022-0458
  • 64785722.0.0000.5327 (Other Identifier: Ethics Committee - Brazilian Government (CEP/Conep))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attention Deficit Disorder With Hyperactivity

Clinical Trials on Exam

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe